Cost-effectiveness of lung volume reduction coil treatment in patients with severe emphysema: results from the 2-year follow-up crossover REVOLENS study (REVOLENS-2 study)
暂无分享，去创建一个
A. Cuvelier | N. Roche | C. Marquette | J. Vergnon | L. Thiberville | S. Leroy | I. Durand-zaleski | F. Costes | H. Mal | C. Pison | H. Vallerand | G. Deslée | E. Hachulla | F. Lebargy | J. Benzaquen | M. Debray | F. Brégeon | D. Makris | D. Gras | A. Bourdin | D. Dusser | R. Kessler | A. Briault | N. Lesavre | F. Fourrier | A. Marceau | M. Buscot | V. Jounieaux | S. Laroumagne | H. Dutau | P. Astoul | E. Reymond | F. Arbib | Philippe Benoît | B. Renaud-Picard | S. Dury | J. Perotin | C. Launois | Carine Gomez | A. Mazzetta | A. Gamez | F. Servin | M. Salaün | M. Porzio | C. Barbe | S. Lachkar | D. Jolly | J. Bulsei | J. Mallet | C. Sanfiorenzo | Sylvain Dukic | J. Griffonnet | Y. Thibout | B. Toublanc | F. Di Palma | M. Bonnaire | Sandra Hervé François Claire Johanna Jonathan Matthieu Ce Dury Vallerand Lebargy Launois Pradelli Be | J. Pradelli | S. Korzeniewski | A. Guillemart | Christine Dombret | P. Tarodo | Christophe Brousse | Clément Broissin | G. Ferrettti | G. François | Annick Leclainche | Matthieu Buscot | B. Renaud-Picard